Fenpropimorph

Fenpropimorph

SCHEMBL7953741

C[C@@H](Cc1ccc(C(C)(C)C)cc1)CN1C[C@@H](C)O[C@@H](C)C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 5/20 1.00
EBP Q15125 1/20 1.00
ADORA3 P0DMS8 1/20 0.79
CHRM1 P11229 1/20 0.79
DRD3 P35462 1/20 0.79
KCNH2 Q12809 1/20 0.79
ALDH1A1 P00352 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 2/20 0.41
ACACB O00763 5/20 0.38
KDM4E B2RXH2 1/20 0.37
HSD17B10 Q99714 1/20 0.37
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fenpropimorph SCHEMBL22362 1.00 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL12473532 1.00 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL29455102 1.00 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL22363 1.00 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL9020991 1.00 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL30367069 1.00 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL9164245 1.00 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL3710231 0.99 SIGMAR1 (0.97) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL3710228 0.99 SIGMAR1 (0.97) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL465559 0.93 SIGMAR1 (0.86) SIGMAR1EBPADORA3CHRM1DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100092479-A1 Compositions and methods for treatment of viral diseases COMBINATORX (SINGAPORE) PTE. LTD. (SG) 2010-04-15 US disclosed
US-20100092479-A1 Compositions and methods for treatment of viral diseases COMBINATORX (SINGAPORE) PTE. LTD. (SG) 2010-04-15 US disclosed
WO-2010021681-A2 COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES COMBINATORX (SINGAPORE) PTE. LTD. (SG) 2010-02-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100092479-A1 Compositions and methods for treatment of viral diseases HAVCR2, RNASE1, EIF2AK2 SIGMAR1 2617/4885EBP 529/4885ADORA3 559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.